Third Harmonic Bio, Inc. (THRD)
Jul 31, 2025 - THRD was delisted
5.38
-0.00 (-0.09%)
Inactive · Last trade price on Jul 30, 2025

Third Harmonic Bio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingMar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Income
-64.3-58.87-43.95-37.71-19-11.12
Net Income
-53.45-45.47-30.82-35.16-29.61-12.81
Earnings Per Share
-1.25-1.09-0.78-2.45-7.32-3.49
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingMar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
271.61285.06269.07288.88128.288.28
Total Debt
33.213.954.34--
Net Cash (Debt)
268.61281.86265.12284.54128.288.28
Net Cash Growth
3.69%6.31%-6.83%121.81%1449.84%-
Net Cash Per Share
6.266.756.6919.8231.732.26

Cash Flow & CapEx

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingMar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
-41.69-34.5-20.43-34.92-15.75-9.19
Capital Expenditures
-0.01-0.01-0.17-0.04--
Free Cash Flow
-41.7-34.51-20.59-34.95-15.75-9.19
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.